These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17998944)

  • 1. Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer.
    Boccardo F
    Nat Clin Pract Oncol; 2008 Feb; 5(2):76-7. PubMed ID: 17998944
    [No Abstract]   [Full Text] [Related]  

  • 2. Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer.
    Med Lett Drugs Ther; 2003 Mar; 45(1152):22-3. PubMed ID: 12637893
    [No Abstract]   [Full Text] [Related]  

  • 3. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M
    J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R
    Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer drug shows promise for some survivors.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Oct; 14(21):7-9. PubMed ID: 14628765
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
    Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
    Needleman SJ; Tobias JS
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1871-81. PubMed ID: 19046107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
    Stilwill SE; Cooper BC
    J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
    Okunade G; Green AR; Ying M; Agrawal A; Paish EC; Aleskandrany M; Winterbottom L; Hassell K; Morgan DA; Ellis IO; Cheung KL
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):76-82. PubMed ID: 19515574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal hemorrhages in anastrozole users.
    Eisner A; Falardeau J; Toomey MD; Vetto JT
    Optom Vis Sci; 2008 May; 85(5):301-8. PubMed ID: 18451730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term insurance for breast cancer survivors.
    Johns Hopkins Med Lett Health After 50; 2004 Apr; 16(2):3, 7. PubMed ID: 15088564
    [No Abstract]   [Full Text] [Related]  

  • 13. Anastrozole called breast cancer "lifesaver". Recipients showed a 40 percent decrease in relapse risk when switched to anastrazole after tamoxifen.
    Health News; 2005 Dec; 11(12):13-4. PubMed ID: 16416553
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
    Lejbak L; Vrbancic M; Crossley M
    J Clin Exp Neuropsychol; 2010 Oct; 32(8):836-46. PubMed ID: 20336566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
    Schwartzberg LS; Cobb P; Senecal F; Henry D; Kulig K; Walker MS; Houts AC; Stepanski EJ
    Breast; 2009 Apr; 18(2):78-83. PubMed ID: 19342237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
    Goss PE; Ingle JN; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Tu D
    J Clin Oncol; 2008 Apr; 26(12):1948-55. PubMed ID: 18332475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole as adjuvant therapy for postmenopausal women with early breast cancer.
    Russell CA
    Manag Care Interface; 2007 Sep; 20(9):30-1, 36. PubMed ID: 18161388
    [No Abstract]   [Full Text] [Related]  

  • 18. Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
    Geisler J; Helle H; Ekse D; Duong NK; Evans DB; Nordbø Y; Aas T; Lønning PE
    Clin Cancer Res; 2008 Oct; 14(19):6330-5. PubMed ID: 18829517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment boosts outlook for breast cancer survivors.
    Mayo Clin Womens Healthsource; 2004 Mar; 8(3):3. PubMed ID: 15001847
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.
    Lipton A; Leitzel K; Chaudri-Ross HA; Evans DB; Ali SM; Demers L; Hamer P; Brown-Shimer S; Pierce K; Gaur V; Carney W
    J Clin Oncol; 2008 Jun; 26(16):2653-8. PubMed ID: 18443351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.